Antineoplastic agents in pancreatic cancer-related clinical trials
(september 2008) - Composés antinéoplasiques en essais cliniques
relatifs au cancer du pancréas (septembre 2008)

Alanosine, Aldesleukin, Angiopeptin, Arsenic trioxide

BBR 3464, Bevacizumab, Bleomycin, Bortezomib, Bryostatin 1

Camptothecin, Capecitabine, Cetuximab, Cyclophosphamide

Denileukin diftitox, Dexamethasone, Docetaxel, Dolastatin 10,
Doxorubicin, DX 8951

Epothilone B, Epothilones, Etoposide, Etoposide phosphate

Flavopiridol, Floxuridine, Fludarabine, Fludarabine monophosphate,
Fluorouracil, FR 901228

Gefitinib, Gemcitabine, Genistein

Ifosfamide, Imatinib, Interferon Alfa-2a, Interferon Alfa-2b,
Interferon Type I (Recombinant), Interleukin-12, Irinotecan,
Irofulven, Isophosphamide mustard

Lanreotide, Lapatinib, Lenalidomide

Mechlorethamine, Megestrol, Megestrol Acetate, Melphalan, Mitomycins,
Motexafin gadolinium

O-(chloroacetylcarbamoyl)fumagillol, Octreotide, Oxaliplatin

Antineoplastic agents in bladder cancer-related clinical trials
(september 2008) - Composés antinéoplasiques en essais cliniques
relatifs au cancer de la vessie (septembre 2008)

Arsenic trioxide

Bevacizumab, Bortezomib

Camptothecin, Capecitabine, Cetuximab

Decitabine, Docetaxel, Doxorubicin,

EO 9, Epigallocatechin gallate, Epirubicin, Epothilone B, Epothilones,
Etoposide, Etoposide phosphate

Fenretinide, Fluorouracil, FR 901228

Gefitinib, Gemcitabine, Genistein

Ifosfamide, Interferon Alfa-2a, Interferon Alfa-2b, Interferon Type I
(Recombinant), Interleukin-12, Irinotecan, Isophosphamide mustard

Lapatinib

Mechlorethamine, Methotrexate, Mitomycins, Motexafin gadolinium

Oxaliplatin

Paclitaxel, Pemetrexed, Piritrexim

Retinol palmitate

Sirolimus, Sorafenib, Suberoylanilide hydroxamic acid, Sunitinib

Antineoplastic agents in lung cancer-related clinical trials
(september 2008) - Composés antinéoplasiques en essais cliniques
relatifs au cancer du poumon (septembre 2008)

Alanosine, Aldesleukin, Amrubicin, Angiostatins, Arsenic trioxide,
Azacitidine,

BBR 3464, Bendamustine, Bevacizumab, Bexarotene, Bleomycin,
Bortezomib, Bryostatin 1, Busulfan

Camptothecin, Capecitabine, Carboxyamido-triazole, Cetuximab,
Combretastatin, Combretastatin A-4, Cyclophosphamide

Dacarbazine, Decitabine, Denileukin diftitox, Dexamethasone,
Docetaxel, Doxorubicin, DX 8951

Endostatins, Epigallocatechin gallate, Epirubicin, Epothilone B,
Epothilones, Etoposide, Etoposide phosphate

Farnesylthiosalicylic acid, Fenretinide, Flavopiridol, Fludarabine,
Fludarabine monophosphate, Fluorouracil, FR 901228, Fulvestrant

Gefitinib, Gemcitabine

Ifosfamide, Imatinib, Interferon Alfa-2a, Interferon Alfa-2b,
Interferon Type I (Recombinant), Interleukin-12, Irinotecan,
Irofulven, ISIS 5132, Isophosphamide mustard

Antineoplastic agents in breast cancer-related clinical trials
(september 2008) - Composés antinéoplasiques en essais cliniques
relatifs au cancer du sein (septembre 2008)

Aldesleukin, Alemtuzumab, Alitretinoin, Aminoglutethimide, Amonafide,
Amrubicin, Anastrozole, Angiopeptin, Annamycin, Arsenic trioxide,
Azacitidine

Bendamustine, Bevacizumab, Bexarotene, Bicalutamide, Bleomycin,
Bortezomib, Bryostatin 1, Busulfan

Camptothecin, Capecitabine, Carboxyamido-triazole, Carmustine,
Cetuximab, Clofarabine, Cyclophosphamide

Dacarbazine, Daunorubicin, Decitabine, Denileukin diftitox,
Dexamethasone, Docetaxel, Doxorubicin, DX 8951

Ecteinascidin 743, Endostatins, Epigallocatechin gallate, Epirubicin,
Epothilone B, Epothilones, Estramustine, Etoposide, Etoposide
phosphate, Exemestane

Fenretinide, Flavopiridol, Fludarabine, Fludarabine monophosphate,
Fluorouracil, FR 901228, Fulvestrant

Gefitinib, Gemcitabine, Genistein, Goserelin

Luc wrote:

Cancers and other neoplasms in clinical trials

Abdominal neoplasms, adenocarcinoma, adenocarcinoma (bronchiolo-
alveolar), adenocarcinoma (clear cell), adenocarcinoma (follicular),
adenoma, adenoma (islet cell), adenoma (pleomorphic), adenomatous
polyposis Coli, adenomatous polyps, adrenal cortex neoplasms, adrenal
gland neoplasms, adrenocortical carcinoma, angiomyolipoma, appendiceal
neoplasms, astrocytoma

Basal cell nevus syndrome, bile duct neoplasms, biliary tract
neoplasms, blast crisis, bone cysts, bone marrow neoplasms, bone
neoplasms, Bowen's disease, brain neoplasms, brain stem neoplasms,
breast cyst, breast neoplasms, breast neoplasms (male), Burkitt
lymphoma

Carcinoid tumor, carcinoma, carcinoma (in situ), carcinoma (adenoid
cystic), carcinoma (adenosquamous), carcinoma (basal cell), carcinoma
(bronchogenic), carcinoma (ductal), carcinoma (ductal, breast)...

"Wim" schreef in bericht
news:0o8zk.21157$t_1.2334@newsfe30.ams2...

Beste;

dit kan zo niet beantwoord worden.

Hoi;

kan er me iemand in eenvoudige taal - ik ben niet heel hoog opgeleid -
uitleggen hoe je nu met de Hubble in de tijd kan terugkijken?

Ik kan begrijpen dat je nu met de hubble kan zien wat er NU gebeurd zo'n
5000 lichtjaren van hier verwijderd ( ik zeg maar wat ) terwijl we dat
anders pas binnen 5000 jaar gingen zien omdat we 5000 lichtjaar 'ver-kijken'
maar ik kan niet begrijpen hoe je dingen kan zien die reeds lang geleden
hebben plaatsgevonden door zover doorheen de ruimte te kijken. Hoe kunnen ze
nu ' bijna' de big-bang zien door zo ver in de ruimte te kijken naar een
locatie van waaruit alles is begonnen? Daar is dit fenomeen toch niet meer
aanwezig?

tx;

Luc

Antineoplastic agents in clinical trials (september 2008) - Composés
antinéoplasiques en essais cliniques (septembre 2008)

Alanosine, Albendazole, Aldesleukin, Alemtuzumab, Alitretinoin, Allyl
sulphide, Altretamine, Aminoglutethimide, Ammonium
trichloro(dioxoethylene-O,O'-)tellurate, Amonafide, Amrubicin,
Anastrozole, Angiopeptin, Angiostatins, Annamycin, Arginine butyrate,
Arsenic trioxide, Ascorbate-2-phosphate, Azacitidine, Azathioprine,
Azelaic acid

BBR 3464, Bendamustine, Betulinic acid, Bevacizumab, Bexarotene,
Bicalutamide, Bizelesin, Bleomycin, Bortezomib, Bromodeoxyuridine,
Bryostatin 1, Busulfan, Buthionine Sulfoximine

Cabergoline, Camptothecin, Capecitabine, Carboxyamido-triazole,
Carmustine, Cetuximab, Chlorambucil, Cidofovir, Clofarabine,
Colchicine, Combretastatin, Combretastatin A-4, Cordycepin,
Cyclophosphamide, Cytarabine

Dacarbazine, Dactinomycin, Daunorubicin, Decitabine, Denileukin
diftitox, Dexamethasone, Dienogest, Diethylstilbestrol, Docetaxel,
Dofequidar, Dolastatin 10, Doxifluridine, Doxorubicin, DX 8951

Sociétés de biotechnologies en Wallonie (Belgique) - Biotech companies
in Wallonia (Belgium)

Affiland, Agrostar, Analis, Arlenda, Artechno, Avecon, Baxter
Healthcare, Beldem, Belovo, Biochem Europe, Biocode-Hycel, BioPharma,
Bioplant in Vitro, Biopole, Biorem, Biosource, Biotreatment, BioXpr,...